Lynparza bags positive prostate cancer results
The drug more than doubled median radiographic progression-free survival.
Read More
Tag: PROfound
Myriad, AstraZeneca and MSD expand collaboration
The expansion will use BRACAnalysis CDx to identify germline BRCA mutations.
Read More
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
